Related Experiment Video
Updated: Aug 2, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
DNA topoisomerases and topoisomerase inhibitors
1Department of Oncology, Free University Hospital, Amsterdam, The Netherlands.
Abstract:
DNA topoisomerases are ubiquitous nuclear enzymes, essential for several steps of DNA metabolism. They have recently been shown to be specific targets of a number of anticancer agents. In this review are discussed the most recent discoveries in the physiology and the molecular biology of DNA topoisomerases, and the mechanism of interaction with drugs. In addition, alterations of DNA topoisomerases are also described, as potential responsible of drug resistance.
Insights
DNA topoisomerases are crucial enzymes for DNA metabolism and are targets for anticancer drugs. This review covers their latest discoveries, drug interactions, and roles in drug resistance.
Area of Science:
- Molecular Biology
- Biochemistry
- Pharmacology
Background:
- DNA topoisomerases are essential nuclear enzymes involved in DNA metabolism.
- These enzymes are recognized as key targets for various anticancer agents.
- Understanding their function is critical for developing new cancer therapies.
Purpose of the Study:
- To review recent advancements in the physiology and molecular biology of DNA topoisomerases.
- To elucidate the mechanisms by which anticancer drugs interact with DNA topoisomerases.
- To explore the role of DNA topoisomerase alterations in anticancer drug resistance.
Main Methods:
- Literature review of recent discoveries in DNA topoisomerase research.
- Analysis of molecular mechanisms of drug-enzyme interactions.
- Examination of studies on genetic and epigenetic alterations in DNA topoisomerases.
Main Results:
- Recent discoveries highlight the complex roles of DNA topoisomerases in DNA replication, transcription, and repair.
- The review details specific drug-enzyme interactions, including those involving topoisomerase inhibitors.
- Alterations in DNA topoisomerase expression or function are frequently associated with acquired resistance to chemotherapy.
Conclusions:
- DNA topoisomerases are vital targets in oncology, with ongoing research revealing new therapeutic strategies.
- Further investigation into drug-enzyme interactions and resistance mechanisms is essential for improving cancer treatment efficacy.
- Targeting DNA topoisomerases remains a promising avenue for novel anticancer drug development.
Related Concept Videos
DNA Helicases
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Drugs that Destabilize Microtubules
Inhibitors of Bacterial DNA Synthesis
Antiviral Nucleoside Inhibitors

